These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21054664)

  • 1. Virological tools to diagnose and monitor hepatitis C virus infection.
    Chevaliez S
    Clin Microbiol Infect; 2011 Feb; 17(2):116-21. PubMed ID: 21054664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to use virological tools for optimal management of chronic hepatitis C.
    Chevaliez S; Pawlotsky JM
    Liver Int; 2009 Jan; 29 Suppl 1():9-14. PubMed ID: 19207960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to use virological tools for the optimal management of chronic hepatitis C.
    de Leuw P; Sarrazin C; Zeuzem S
    Liver Int; 2011 Jan; 31 Suppl 1():3-12. PubMed ID: 21205131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of hepatitis C core antigen in therapy monitoring for chronic hepatitis C.
    Moscato GA; Giannelli G; Grandi B; Pieri D; Marsi O; Guarducci I; Batini I; Altomare E; Antonaci S; Capria A; Pellegrini G; Sacco R
    Intervirology; 2011 Feb; 54(2):61-5. PubMed ID: 20829601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
    Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
    J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
    J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of hepatitis C virus using an in-house real-time reverse transcriptase polymerase chain reaction in plasma samples.
    Daniel HD; Grant PR; Garson JA; Tedder RS; Chandy GM; Abraham P
    Diagn Microbiol Infect Dis; 2008 Aug; 61(4):415-20. PubMed ID: 18486403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
    Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
    J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay.
    Medici MC; Furlini G; Rodella A; Fuertes A; Monachetti A; Calderaro A; Galli S; Terlenghi L; Olivares M; Bagnarelli P; Costantini A; De Conto F; Sainz M; Galli C; Manca N; Landini MP; Dettori G; Chezzi C
    J Clin Virol; 2011 Aug; 51(4):264-9. PubMed ID: 21621454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance evaluation of the Artus hepatitis C virus QS-RGQ assay.
    Paba P; Fabeni L; Perno CF; Ciotti M
    J Virol Methods; 2012 Jan; 179(1):77-80. PubMed ID: 22001273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-four mini-pool HCV RNA screening in a routine clinical virology laboratory setting: a six-year prospective study.
    Seme K; Mocilnik T; Poljak M
    J Virol Methods; 2011 Jan; 171(1):303-5. PubMed ID: 21087636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
    Alzahrani AJ
    J Med Virol; 2008 Apr; 80(4):603-6. PubMed ID: 18297713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of core antigen detection in management of hepatitis C: a critical review.
    Seme K; Poljak M; Babic DZ; Mocilnik T; Vince A
    J Clin Virol; 2005 Feb; 32(2):92-101. PubMed ID: 15653411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve week post-treatment undetectable hepatitis C virus (HCV)-RNA by PCR assay predicts a sustained virological response to anti-HCV therapy independently from immunological status of the infected patients.
    Donato MF; Bastiampillai AJ; Manini M; Monico S
    J Antimicrob Chemother; 2013 Apr; 68(4):974-5. PubMed ID: 23221629
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.
    Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M; Conway B; Robaeys G; Swan T; Cloherty G; Marks P; Grebely J; Dore GJ; Applegate TL
    J Clin Virol; 2017 Jul; 92():32-38. PubMed ID: 28521211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.